Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.
All medicines have risks as well as benefits.
The aim of EIPICO.'s Pharmacovigilance Department is to enhance patient's health and safety in relation to the use of EIPICO.'s products through providing reliable, and balanced information to ensure that the overall benefits of medicines outweigh the risks.
Such aim is fulfilled by collecting Adverse Drug Reaction Reports/Customer Complaints and preparing Pharmacovigilance documents for each of EIPICO.'s marketed products routinely, to assess the medicines Benefit/Risk balance.
Thus, by reporting Adverse Drug Reactions/Complaints witnessed from a drug, we share in the continuous monitoring of the safety, efficacy and quality of the drug beside ensuring that the Benefit/Risk balance is updated in order to reach safer medicinal products and have a positive impact on the public safety/health.
Report… Your Report Counts.
You may report any drug-related problem concerning EIPICO.'s medicinal products through: 
- Email: Pharmacovigilance@eipico.net
- Landline No.: (+02) 24143660 - 24143550/Internal No.: 601 - 505 - 509
- Fax No.: (+02) 24174528 - 24143800
For reporting drug-related Problems in the Kingdom of Saudi Arabia throughEgyptian International Pharmaceutical Industries Co. (EIPICO)
Pharmacovigilance Department
Address: 2560 AlMallah, AlMurabba, Unit No. 1, Riyadh 12631-9104
Tel.: +966-11-4056428 # 121/115/116
Fax: +966-11-4123969
Email: icsrs.ksa@eipico.net